Endpoints, reliability, and meaningful changes in clinical trials for children with irritable bowel syndrome. The Rome foundation pediatric subcommittee on clinical trials

M. Saps; J. V. Lavigne; M. A. van Tilburg; A. Miranda; M. A. Benninga; J. A. Taminiau; C. di Lorenzo

doi:https://doi.org/10.1111/nmo.13308

Endpoints, reliability, and meaningful changes in clinical trials for children with irritable bowel syndrome. The Rome foundation pediatric subcommittee on clinical trials

M. Saps, J. V. Lavigne, M. A. van Tilburg, A. Miranda, M. A. Benninga, J. A. Taminiau, C. di Lorenzo

Research output: Contribution to journal › Comment/Letter to the editor › Academic

3 Citations (Scopus)

Original language	English
Article number	e13308
Journal	Neurogastroenterology and Motility
Volume	30
Issue number	5
DOIs	https://doi.org/10.1111/nmo.13308
Publication status	Published - 2018

Access to Document

https://doi.org/10.1111/nmo.13308

Cite this

Saps, M., Lavigne, J. V., van Tilburg, M. A., Miranda, A., Benninga, M. A., Taminiau, J. A., & di Lorenzo, C. (2018). Endpoints, reliability, and meaningful changes in clinical trials for children with irritable bowel syndrome. The Rome foundation pediatric subcommittee on clinical trials. Neurogastroenterology and Motility, 30(5), Article e13308. https://doi.org/10.1111/nmo.13308

@article{93b30e6fce144a9d90ee4add16472c5a,

title = "Endpoints, reliability, and meaningful changes in clinical trials for children with irritable bowel syndrome. The Rome foundation pediatric subcommittee on clinical trials",

author = "M. Saps and Lavigne, {J. V.} and {van Tilburg}, {M. A.} and A. Miranda and Benninga, {M. A.} and Taminiau, {J. A.} and {di Lorenzo}, C.",

year = "2018",

doi = "https://doi.org/10.1111/nmo.13308",

language = "English",

volume = "30",

journal = "Neurogastroenterology and Motility",

issn = "1350-1925",

publisher = "Wiley-Blackwell",

number = "5",

}

Endpoints, reliability, and meaningful changes in clinical trials for children with irritable bowel syndrome. The Rome foundation pediatric subcommittee on clinical trials. / Saps, M.; Lavigne, J. V.; van Tilburg, M. A. et al.
In: Neurogastroenterology and Motility, Vol. 30, No. 5, e13308, 2018.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Endpoints, reliability, and meaningful changes in clinical trials for children with irritable bowel syndrome. The Rome foundation pediatric subcommittee on clinical trials

AU - Saps, M.

AU - Lavigne, J. V.

AU - van Tilburg, M. A.

AU - Miranda, A.

AU - Benninga, M. A.

AU - Taminiau, J. A.

AU - di Lorenzo, C.

PY - 2018

Y1 - 2018

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85045981326&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/29700958

U2 - https://doi.org/10.1111/nmo.13308

DO - https://doi.org/10.1111/nmo.13308

M3 - Comment/Letter to the editor

C2 - 29700958

SN - 1350-1925

VL - 30

JO - Neurogastroenterology and Motility

JF - Neurogastroenterology and Motility

IS - 5

M1 - e13308

ER -

Endpoints, reliability, and meaningful changes in clinical trials for children with irritable bowel syndrome. The Rome foundation pediatric subcommittee on clinical trials

Access to Document

Other files and links

Cite this